2025年迪高替尼软膏正版的价格是多少？

Digotinib ointment is a new JAK inhibitor topical preparation for the treatment of atopic dermatitis. The latest price information in 2025 shows that it still maintains a relatively stable pricing level. This drug has not yet been approved for marketing in mainland China. The main circulating version is the Japanese original drug, which is available in two concentration specifications of 0.25% and 0.5%, and the prices are around US$96 and US$130 respectively. Correct usage and medication for special groups must strictly follow medical guidance to obtain the best therapeutic effect while reducing potential risks.

The price of genuine Digotinib Ointment in 2025

The market price system in 2025 will be basically the same as in previous years. The differences in product pricing of different concentrations and specifications are mainly due to the content of drug ingredients and treatment intensity.

Pricing for 0.25% concentration specification

The price of 0.25% concentration product in 5g/tube specification remains at around US$96 for a box of 10 tubes. This specification is suitable for patients with mild to moderate symptoms, especially for children.

Pricing for 0.5% concentration specifications

For 0.5% concentration products in 5 g/tube specification, the price for a box of 10 units is approximately US$130. The higher concentration version targets moderate to severe symptoms in adults and has a more significant therapeutic effect.

The price may vary slightly due to purchase channels, transportation costs and exchange rate fluctuations. It is recommended to obtain the latest quotation through formal medical channels.

Usage of Digotinib Ointment

There are obvious differences in the usage and dosage of different groups of people, so doctor’s instructions must be strictly followed.

Usage instructions for adult patients

It is recommended to use 0.5% ointment and apply appropriate amount to the affected area twice a day. The maximum single dose should not exceed 5 grams. If the treatment is ineffective after 4 weeks, adjustment of the plan should be considered.

Instructions for use in pediatric patients

Children over 2 years old should use 0.25% concentration twice a day. Based on symptom evaluation, you may consider upgrading to a concentration of 0.5%, but the dosage must be strictly controlled.

The affected area should be cleaned before use. After application, gently massage until fully absorbed. Avoid contact with eyes and mucous membranes.

Usage of Digotinib Ointment for Special Populations

People with specific physiological conditions need to be extra cautious when using Digotinib Ointment, and should use it under the supervision of a professional physician when necessary.

Principles for use in pregnant women

Animal experiments show that high doses may be embryotoxic. Pregnant women must strictly evaluate the benefits and potential risks of treatment and give priority to alternative treatment options.

Precautions for lactating women

Drug ingredients may be secreted through breast milk. If used during lactation, breastfeeding must be suspended or other treatment methods selected. The specific plan shall be formulated by a professional physician.

Pediatric Medication Specifications

Infants and young children over 6 months old need to accurately calculate the dose based on body weight. Infants under 6 months old are contraindicated. There is a lack of effectiveness and safety data to support this age group.

Elderly patients and those with hepatic and renal insufficiency need to strengthen monitoring when using it, and adjust the medication regimen if necessary.